Intrastriatal administration of 5-aminolevulinic acid induces convulsions and body asymmetry through glutamatergic mechanisms

Brain Research

Volumn 868, Issue 1, 2000, Pages 88-94

  Emanuelli, Tatiana ^a   Prauchner, Carlos André ^d   Dacanal, Jerusa ^d   Zeni, Alexander ^d   Reis, Elisangela Cavalari ^d   De Mello, Carlos Fernando ^b   De Souza, Diogo Onofre ^c  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b Univ F   (Brazil)

^c U   (Brazil)

^d NONE

Author keywords

Aminobutyric acid; 5 Aminolevulinic acid; Body asymmetry; Convulsion; Glutamate; Striatum

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; 6,7 DINITRO 2,3 QUINOXALINEDIONE; AMINOLEVULINIC ACID; DIZOCILPINE; GLUTAMATE RECEPTOR ANTAGONIST; MUSCIMOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; CONVULSION; FEMALE; LOCOMOTION; NEUROTRANSMISSION; NONHUMAN; PORPHYRIA; PRIORITY JOURNAL; RAT; SEIZURE;

AMINOLEVULINIC ACID; ANIMALS; CONVULSANTS; CORPUS STRIATUM; DIZOCILPINE MALEATE; EPILEPSY; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GABA AGONISTS; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; MICROINJECTIONS; MUSCIMOL; QUINOXALINES; RATS; RATS, WISTAR;

EID: 0034674611     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02327-1     Document Type: Article

References (28)

1. Becker D., Viljoen D., Kramer S. The inhibition of red cell and brain ATPase by delta-aminolaevulinic acid. Biochim. Biophys. Acta. 225:1971;26-34.
2. Bonkowsky H.L., Sinclair P.R., Emery S., Sinclair J.F. Seizure management in acute hepatic porphyria: risks of valproate and clonazepan. Neurology. 30:1980;588-592.
3. Borlangan C.V., Sanberg P.R. Elevated body swing test: a new behavioral parameter for rats with 6-hydroxydopamine-induced hemiparkinsonism. J. Neurosci. 15:1995;5372-5378.
4. Brennan M.J.W., Cantrill R.C. Delta-aminolevulinic acid is a potent agonist for GABA autoreceptors. Nature (London). 280:1979;514-515.
5. Brennan M.J.W., Cantrill R.C. The effect of delta-aminolaevulinic acid on the uptake and efflux of amino acid neurotransmitters in rat brain synaptosomes. J. Neurochem. 33:1979;721-725.
6. Bylesjö I., Forsgren L., Lithner F., Boman K. Epidemiology and clinical characteristics of seizures in patients with acute intermittent porphyria. Epilepsia. 37:1996;230-235.
7. Cutler M.G., Moore M.R., Ewart F.G. Effects of delta-aminolaevulinic acid administration on social behavior in the laboratory mouse. Psychopharmacology. 61:1979;131-135.
8. Demasi M., Penatti C.A.A., DeLucia R., Bechara E.J.H. The prooxidant effect of 5-aminolevulinic acid in the brain tissue of rats: implications in neuropsychiatric manifestations in porphyrias. Free Rad. Med. Biol. 20:1996;291-299.
9. Fighera M.R., Queiroz C.M., Stracke M.P., Nin Brauer M.C., González-Rodríguez L.L., Frussa-Filho R., Wajner M., Mello C.F. Ascorbic acid and α-tocopherol attenuate methylmalonic acid-induced convulsions. NeuroReport. 10:1999;2039-2043.
10. Juknat A.A., Kotler M.L., Batlle A.M.C. High δ-aminolevulinic acid uptake in rat cerebral cortex: effect on pophyrin biosynthesis. Comp. Biochem. Physiol. 111C:1995;143-150.
11. Kappas A., Sassa S., Galbraith R.A., Nordmann Y. The porphyrias. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The Metabolic Bases of Inherited Disease. 7th Edition :1995;2103-2160 McGraw Hill, New York.
12. Klaassen C.D. Heavy metals and heavy-metal antagonists. Wonsiewics M.J., McCurdy P. The Pharmacological Basis of Therapeutics. 1996;1649-1671 McGraw-Hill, New York.
13. Lees G.J., Leong W. NBQX prevents contralateral but not ipsilateral seizure-induced cytotoxicity of kainate but not AMPA-reversal at high doses of NBQX. NeuroReport. 5:1994;2153-2156.
14. Lima T.T.F., Begnini J., Bastiani J., Fialho D.B., Jurach A., Ribeiro M.C.P., Wajner M., Mello C.F. Pharmacological evidence for GABAergic and glutamatergic involvement in the convulsant and behavioral effects of glutaric acid. Brain Res. 802:1998;55-60.
15. Löscher W. Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy. Prog. Neurobiol. 54:1998;721-741.
16. Matteis F., Ray D.E. Studies on cerebellar haem metabolism in the rat in vivo. J. Neurochem. 39:1982;551-556.
17. McGillion F.B., Moore M.R., Goldberg A. The effect of delta-aminolevulinic acid on the spontaneous activity of mice. Scot. Med. J. 18:1973;133.
18. McGillion F.B., Thompson G.G., Goldberg A. Tissue uptake of δ-aminolevulinic acid. Biochem. Pharmacol. 24:1975;299-301.
19. McLoughlin J.L., Cantrill R.C. The effect of delta-aminolaevulinic acid on the high affinity uptake of aspartic acid by rat brain synaptosomes. Gen. Pharmacol. 15:1984;553-555.
20. Meldrum B.S. Neurotransmission in epilepsy. Epilepsia. 36:(Suppl. 1):1995;S30-S35.
21. Mello C.F., Benigni J., Jimenez-Bernal M.A., Rubin J., Bastiani E., Costa E., Wajner M. Intrastriatal methylmalonic acid administration induces rotational behaviour and convulsions through glutamatergic mechanisms. Brain Res. 721:1996;120-125.
22. Pierach C.A., Edwards P.S. Neurotoxicity of δ-aminolevulinic acid and porphobilinogen. Exp. Neurol. 62:1978;810-814.
23. Sakai T. Y. Morita, δ-Aminolevulinic acid in plasma or whole blood as a sensitive indicator of lead effects, and its relation to the other heme-related parameters. Int. Arch. Occup. Environ. Health. 68:1996;126-132.
24. Sassa S., Kappas A. Hereditary tyrosinemia and the heme biosynthetic pathway. J. Clin. Invest. 71:1983;625-634.
25. Scheel-Kruger J. Dopamine-GABA interactions: evidence that GABA transmits, modulates and mediates dopaminergic functions in the basal ganglia and the limbic system. Acta Neurol. Scand. 73:1986;9-49.
26. Schuller J.J., Tran D.D., Marshall J.F. Striatal glutamate antagonism induces contralateral neglect. Brain Res. 788:1998;315-319.
27. Shanley B.C., Neathling A.C., Percy V.A., Carstens M. Neurochemical aspects of porphyria: studies on the possible neurotoxicity of δ-aminolevulinic acid. S. Afr. J. Lab. Clin. Med. 49:1975;576-580.
28. Smith I.D., Todd M.J., Beninger R.J. Glutamate receptor agonist injections into the dorsal striatum cause contralateral turning in the rat: involvement of kainate and AMPA receptors. Eur. J. Pharmacol. 301:1996;7-17.